HSP90AA1 and cancer: Given the fact that only limited number of addicted oncogenic kinases have been identified while fewer can be targeted effectively, Hsp90 inhibition should be considered as a promising alternative approach to be applied in oncogene driving cancer sub-types those newly discovered but can't be reached by specific kinase inhibitors yet.